Overall, these results suggest that the TLR4/MyD88/NF-κB pathway is a bridge between RAS, SNS and hypertension, and provides a novel treatment therapeutic for hypertension and cardiac hypertrophy caused by hypertension. The gene discussed is TLR4; the disease is hypertensive disorder.